UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039085
Receipt number R000044574
Scientific Title A study for the suppressive effect of the beverage containing low molecular weight glucomannan on the elevation of postprandial blood glucose in healthy subjects -A randomized, placebo-controlled, double-blind, crossover trial-
Date of disclosure of the study information 2020/01/09
Last modified on 2020/07/15 11:33:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study for the suppressive effect of the beverage containing low molecular weight glucomannan on the elevation of postprandial blood glucose

Acronym

A study for the suppressive effect of the beverage containing low molecular weight glucomannan on the elevation of postprandial blood glucose

Scientific Title

A study for the suppressive effect of the beverage containing low molecular weight glucomannan on the elevation of postprandial blood glucose in healthy subjects -A randomized, placebo-controlled, double-blind, crossover trial-

Scientific Title:Acronym

A study for the suppressive effect of the beverage containing low molecular weight glucomannan on the elevation of postprandial blood glucose in healthy subjects

Region

Japan


Condition

Condition

Healthy Japanese subjects

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the suppressive effect of the beverage containing low molecular weight glucomannan on the elevation of postprandial blood glucose

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Blood glucose levels at each measurement point

Key secondary outcomes

1.Blood glucose elevation levels at each measurement point
2.The incremental area under the curve of the blood glucose levels
3.The area under the curve of the blood glucose levels


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Period I:Placebo beverage
Wash out
Period II:Beverage containing low molecular weight glucomannan
Carbohydrate load:retort cooked rice(260g)

Interventions/Control_2

Period I:Beverage containing low molecular weight glucomannan
Wash out
Period II:Placebo beverage
Carbohydrate load:retort cooked rice(260g)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

1. Subjects 20 to 59 years of age
2. Healthy subjects
3. Subjects who have no allergy to the test food containing erythritol
4. Subjects who consent to participate in the study, and can sign the consent form

Key exclusion criteria

1. Subjects who have a medical history of diabetes.
2. Subjects whose fasting blood glucose levels are more than 126 mg/dL
3.Subjects who are under medication or having a history of serious diseases for which medication was required.
4. Subjects who have allergy to food
5. Subjects who have extreme diarrhea
6. Subjects who routinely use medicine, supplements, and/or health food which affect to result of the study
7. Subjects who are planning to become pregnant after informed consent for the current study or are pregnant or lactating
8. Subjects who is considered to be inappropriate to attend the present study by the research contact person

Target sample size

25


Research contact person

Name of lead principal investigator

1st name Kaname
Middle name
Last name Katsuraya

Organization

Wayo Women's University Graduate School

Division name

Faculty of Human Ecology

Zip code

272-8533

Address

2-3-1 konodai, Ichikawa, Chiba, Japan

TEL

047-371-2482

Email

katsuraya@wayo.ac.jp


Public contact

Name of contact person

1st name Mihoko
Middle name
Last name Moto

Organization

Wayo Women's University

Division name

Department of Health and Nutrition

Zip code

272-8533

Address

2-3-1 konodai, Ichikawa, Chiba, Japan

TEL

047-371-2393

Homepage URL


Email

moto@wayo.ac.jp


Sponsor or person

Institute

Wayo Women's University

Institute

Department

Personal name



Funding Source

Organization

Shimonita - Bussan

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Wayo Women's University Research Support Division

Address

2-3-1 konodai, Ichikawa, Chiba, Japan

Tel

047-371-1184

Email

k-shien@wayo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

和洋女子大学(千葉県)


Other administrative information

Date of disclosure of the study information

2020 Year 01 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 01 Month 07 Day

Date of IRB

2019 Year 12 Month 12 Day

Anticipated trial start date

2020 Year 01 Month 27 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 01 Month 08 Day

Last modified on

2020 Year 07 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044574


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name